Cargando…
The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population
BACKGROUND: Early detection could significantly improve the prognosis of coronary heart disease (CHD). In-invitro diagnostic technique may provide a solution when sufficient biomarkers could be identified. Pertinent associations between blood-based aberrant DNA methylation and smoking, the pathogene...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375073/ https://www.ncbi.nlm.nih.gov/pubmed/35964014 http://dx.doi.org/10.1186/s12872-022-02766-8 |
_version_ | 1784767881467133952 |
---|---|
author | Zhu, Liya Zhu, Chao Wang, Jinxin Yang, Rongxi Zhao, Xiaojing |
author_facet | Zhu, Liya Zhu, Chao Wang, Jinxin Yang, Rongxi Zhao, Xiaojing |
author_sort | Zhu, Liya |
collection | PubMed |
description | BACKGROUND: Early detection could significantly improve the prognosis of coronary heart disease (CHD). In-invitro diagnostic technique may provide a solution when sufficient biomarkers could be identified. Pertinent associations between blood-based aberrant DNA methylation and smoking, the pathogenesis of atherosclerosis, and CHD have been robustly demonstrated and replicated, but that studies in Chinese populations are rare. The blood-based methylation of aryl-hydrocarbon receptor repressor (AHRR) cg05575921 and 6p21.33 cg06126421 has been associated with cardiovascular mortality in Caucasians. Here, we aim to investigate whether the AHRR and 6p21.33 methylation in the blood is associated with CHD in the Chinese population. METHODS: In this case–control study, 180 CHD patients recruited at their first registration in our study center, and 184 controls randomly selected from the people who participated in the annual health examination were enrolled. Methylation intensities of 19 CpG sites, including AHRR cg05575921, 6p21.33 cg06126421, and their flanking CpG sites, were quantified by mass spectrometry. The association between methylation intensities and CHD was estimated by logistic regression analyses adjusted for covariant. RESULTS: Compared to the controls, lower methylation of 6p21.33_CpG_4.5/cg06126421 was independently associated with increased odds of being a CHD patient (OR per − 10% methylation = 1.42 after adjustment for age, gender, and batch effect; p = 0.032 by multiple testing corrections). No association between blood-based AHRR methylation and CHD was found. CONCLUSIONS: 6p21.33 methylation exhibits a significant association with CHD. The combination of 6p21.33 methylation and conventional risk factors might be an intermediate step towards the early detection of CHD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-022-02766-8. |
format | Online Article Text |
id | pubmed-9375073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-93750732022-08-14 The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population Zhu, Liya Zhu, Chao Wang, Jinxin Yang, Rongxi Zhao, Xiaojing BMC Cardiovasc Disord Research Article BACKGROUND: Early detection could significantly improve the prognosis of coronary heart disease (CHD). In-invitro diagnostic technique may provide a solution when sufficient biomarkers could be identified. Pertinent associations between blood-based aberrant DNA methylation and smoking, the pathogenesis of atherosclerosis, and CHD have been robustly demonstrated and replicated, but that studies in Chinese populations are rare. The blood-based methylation of aryl-hydrocarbon receptor repressor (AHRR) cg05575921 and 6p21.33 cg06126421 has been associated with cardiovascular mortality in Caucasians. Here, we aim to investigate whether the AHRR and 6p21.33 methylation in the blood is associated with CHD in the Chinese population. METHODS: In this case–control study, 180 CHD patients recruited at their first registration in our study center, and 184 controls randomly selected from the people who participated in the annual health examination were enrolled. Methylation intensities of 19 CpG sites, including AHRR cg05575921, 6p21.33 cg06126421, and their flanking CpG sites, were quantified by mass spectrometry. The association between methylation intensities and CHD was estimated by logistic regression analyses adjusted for covariant. RESULTS: Compared to the controls, lower methylation of 6p21.33_CpG_4.5/cg06126421 was independently associated with increased odds of being a CHD patient (OR per − 10% methylation = 1.42 after adjustment for age, gender, and batch effect; p = 0.032 by multiple testing corrections). No association between blood-based AHRR methylation and CHD was found. CONCLUSIONS: 6p21.33 methylation exhibits a significant association with CHD. The combination of 6p21.33 methylation and conventional risk factors might be an intermediate step towards the early detection of CHD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-022-02766-8. BioMed Central 2022-08-13 /pmc/articles/PMC9375073/ /pubmed/35964014 http://dx.doi.org/10.1186/s12872-022-02766-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Zhu, Liya Zhu, Chao Wang, Jinxin Yang, Rongxi Zhao, Xiaojing The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population |
title | The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population |
title_full | The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population |
title_fullStr | The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population |
title_full_unstemmed | The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population |
title_short | The association between DNA methylation of 6p21.33 and AHRR in blood and coronary heart disease in Chinese population |
title_sort | association between dna methylation of 6p21.33 and ahrr in blood and coronary heart disease in chinese population |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375073/ https://www.ncbi.nlm.nih.gov/pubmed/35964014 http://dx.doi.org/10.1186/s12872-022-02766-8 |
work_keys_str_mv | AT zhuliya theassociationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation AT zhuchao theassociationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation AT wangjinxin theassociationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation AT yangrongxi theassociationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation AT zhaoxiaojing theassociationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation AT zhuliya associationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation AT zhuchao associationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation AT wangjinxin associationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation AT yangrongxi associationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation AT zhaoxiaojing associationbetweendnamethylationof6p2133andahrrinbloodandcoronaryheartdiseaseinchinesepopulation |